Nurix Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $669.3M
Liabilities Breakdown FY2024
Total Liabilities: $142.4M
Asset Breakdown
Total Assets: $669.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $110.0M | 16.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $17.8M | 2.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $541.6M | 80.9% |
Liabilities Breakdown
Total Liabilities: $142.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $11.5M | 8.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $130.9M | 91.9% |